About the Authors

Norma C Serrano

To whom correspondence should be addressed. E-mail: nserrano@unab.edu.co (NCS), Juan.Pablo-Casas@lshtm.ac.uk (JPC)

Affiliation Universidad Aut

Luis A Díaz

Affiliation Universidad Aut

Maria C Páez

Affiliation Universidad Aut

Clara M Mesa

Affiliation Instituto de Ciencias de la Salud, Medell

Rodrigo Cifuentes

Affiliation Universidad del Valle, Cali, Colombia

Alvaro Monterrosa

Affiliation Universidad de Cartagena, Cartagena, Colombia

Adriana González

Affiliation Universidad Industrial de Santander, Bucaramanga, Colombia

Liam Smeeth

Affiliation Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, United Kingdom

Aroon D Hingorani

Affiliation Centre for Clinical Pharmacology, Department of Medicine, at British Heart Foundation laboratories at University College London, London, United Kingdom

Juan P Casas

To whom correspondence should be addressed. E-mail: nserrano@unab.edu.co (NCS), Juan.Pablo-Casas@lshtm.ac.uk (JPC)

Affiliations Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, United Kingdom , Centre for Clinical Pharmacology, Department of Medicine, at British Heart Foundation laboratories at University College London, London, United Kingdom

Competing Interests

University College London holds patents on the measurement of asymmetric dimethylarginine in the management of preeclampsia.

Author Contributions

NCS, LAD, MCP, RC, AM, LS, ADH, and JPC designed the study. NCS, LAD, MCP, CMM, AM, AG, LS, and JPC analyzed the data. NCS, MCP, CMM, RC, AM, AG, and LS enrolled patients. NCS, LAD, MCP, CMM, AM, AG, LS, ADH, and JPC contributed to writing the paper. MCP genotyped the insertion/deletion within the angiotensin-converting enzyme gene and collected the data for the meta-analysis.